• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intravitreal fasudil combined with bevacizumab for persistent diabetic macular edema: a novel treatment.

作者信息

Ahmadieh Hamid, Nourinia Ramin, Hafezi-Moghadam Ali

机构信息

Ophthalmic Research Center, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

JAMA Ophthalmol. 2013 Jul;131(7):923-4. doi: 10.1001/jamaophthalmol.2013.143.

DOI:10.1001/jamaophthalmol.2013.143
PMID:23640178
Abstract
摘要

相似文献

1
Intravitreal fasudil combined with bevacizumab for persistent diabetic macular edema: a novel treatment.
JAMA Ophthalmol. 2013 Jul;131(7):923-4. doi: 10.1001/jamaophthalmol.2013.143.
2
Intravitreal injection of a Rho-kinase inhibitor (fasudil) combined with bevacizumab versus bevacizumab monotherapy for diabetic macular oedema: a pilot randomised clinical trial.玻璃体内注射 Rho 激酶抑制剂（法舒地尔）联合贝伐单抗与贝伐单抗单药治疗糖尿病黄斑水肿的前瞻性随机临床试验。
Br J Ophthalmol. 2019 Jul;103(7):922-927. doi: 10.1136/bjophthalmol-2018-312244. Epub 2018 Aug 27.
3
Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.玻璃体内曲安奈德与玻璃体内联合贝伐单抗和地塞米松治疗弥漫性糖尿病黄斑水肿。
Clin Exp Ophthalmol. 2011 Sep-Oct;39(7):673-81. doi: 10.1111/j.1442-9071.2011.02504.x. Epub 2011 Mar 24.
4
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗持续性弥漫性糖尿病性黄斑水肿。
Retina. 2006 Nov-Dec;26(9):999-1005. doi: 10.1097/01.iae.0000247165.38655.bf.
5
Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.玻璃体内注射贝伐单抗（阿瓦斯汀）对慢性弥漫性糖尿病性黄斑水肿患者的长期影响。
Retina. 2008 Oct;28(8):1053-60. doi: 10.1097/IAE.0b013e318176de48.
6
A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.一项为期12个月的单盲随机对照研究，针对多次抗血管内皮生长因子（anti-VEGF）注射后仍存在糖尿病性黄斑水肿的眼睛，评估地塞米松缓释系统作为贝伐单抗辅助治疗与继续使用贝伐单抗单药治疗相比的疗效。
Retina. 2015 Aug;35(8):1604-14. doi: 10.1097/IAE.0000000000000533.
7
Effect of intravitreal triamcinolone in diabetic macular edema unresponsive to intravitreal bevacizumab.玻璃体内注射曲安奈德对玻璃体内注射贝伐单抗无反应的糖尿病性黄斑水肿的疗效
Retina. 2014 Aug;34(8):1606-11. doi: 10.1097/IAE.0000000000000109.
8
Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial.比较玻璃体内单独使用贝伐单抗或联合曲安奈德与曲安奈德治疗糖尿病性黄斑水肿的疗效：一项随机临床试验。
Ophthalmologica. 2012;227(2):100-6. doi: 10.1159/000331935. Epub 2011 Oct 12.
9
Is intravitreal bevacizumab treatment effective in diffuse diabetic macular edema?
Graefes Arch Clin Exp Ophthalmol. 2009 Nov;247(11):1575-7. doi: 10.1007/s00417-009-1132-4. Epub 2009 Jul 7.
10
Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.糖尿病性黄斑水肿在抗血管内皮生长因子治疗过程中的功能和形态变化。
Acta Ophthalmol. 2013 Nov;91(7):e529-36. doi: 10.1111/aos.12153. Epub 2013 May 7.

引用本文的文献

1
Ocular effects of Rho kinase (ROCK) inhibition: a systematic review.Rho激酶（ROCK）抑制的眼部效应：一项系统评价。
Eye (Lond). 2024 Dec;38(18):3418-3428. doi: 10.1038/s41433-024-03342-4. Epub 2024 Sep 16.
2
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.抗血管内皮生长因子治疗糖尿病性黄斑水肿：一项网状Meta分析。
Cochrane Database Syst Rev. 2023 Jun 27;2023(6):CD007419. doi: 10.1002/14651858.CD007419.pub7.
3
High Glucose Aggravates Retinal Endothelial Cell Dysfunction by Activating the RhoA/ROCK1/pMLC/Connexin43 Signaling Pathway.
高糖通过激活 RhoA/ROCK1/pMLC/Cx43 信号通路加重视网膜内皮细胞功能障碍。
Invest Ophthalmol Vis Sci. 2022 Jul 8;63(8):22. doi: 10.1167/iovs.63.8.22.
4
Combined intravitreal injection of bevacizumab and a ROCK inhibitor (fasudil) for refractory macular edema secondary to retinal vein occlusion: a pilot study.玻璃体内联合注射贝伐单抗和一种ROCK抑制剂（法舒地尔）治疗视网膜静脉阻塞继发的难治性黄斑水肿：一项初步研究。
Int J Retina Vitreous. 2022 Jun 11;8(1):37. doi: 10.1186/s40942-022-00389-x.
5
Evaluation of an Intravitreal Rho-Associated Kinase Inhibitor Depot Formulation in a Rat Model of Diabetic Retinopathy.在糖尿病性视网膜病变大鼠模型中对玻璃体内 Rho 相关激酶抑制剂长效注射制剂的评估。
Pharmaceutics. 2021 Jul 21;13(8):1105. doi: 10.3390/pharmaceutics13081105.
6
Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema.Rho 激酶抑制剂治疗难治性糖尿病黄斑水肿。
Cells. 2021 Jul 3;10(7):1683. doi: 10.3390/cells10071683.
7
Rho kinase inhibitors-a review on the physiology and clinical use in Ophthalmology.Rho激酶抑制剂——眼科生理学及临床应用综述
Graefes Arch Clin Exp Ophthalmol. 2019 Jun;257(6):1101-1117. doi: 10.1007/s00417-019-04283-5. Epub 2019 Mar 7.
8
Effect of ripasudil on diabetic macular edema.利帕舒地尔对糖尿病性黄斑水肿的影响。
Sci Rep. 2019 Mar 6;9(1):3703. doi: 10.1038/s41598-019-40194-5.
9
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.抗血管内皮生长因子治疗糖尿病性黄斑水肿：一项网状Meta分析。
Cochrane Database Syst Rev. 2018 Oct 16;10(10):CD007419. doi: 10.1002/14651858.CD007419.pub6.
10
ROCK-1 mediates diabetes-induced retinal pigment epithelial and endothelial cell blebbing: Contribution to diabetic retinopathy.ROCK-1 介导糖尿病诱导的视网膜色素上皮细胞和内皮细胞泡状突起：对糖尿病性视网膜病变的影响。
Sci Rep. 2017 Aug 18;7(1):8834. doi: 10.1038/s41598-017-07329-y.